WANT A PROFILE LIKE THIS?

Create my FREE Plan Or learn about other options

Javascript is disabled in your browser. Please enable Javascript to view PeerJ.

PeerJ Author

275 Points

Contributions by role

Contributions by subject area

Barbara Lettiero

PeerJ Author

Summary

Cell Biology Immunology Molecular Biology Oncology

Past or current institution affiliations

Lund University

Work details

postdoc

Cancer Center at Lund University

Oncology

PeerJ Contributions

Articles 1
Preprints 3

February 26, 2015

Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours

Jillian Howlin, Helena Cirenajwis, Barbara Lettiero, Johan Staaf, Martin Lauss, Lao Saal, Åke Borg, Sofia Gruvberger-Saal, Göran Jönsson

https://doi.org/10.7717/peerj.788 PubMed 25755924

August 11, 2017 - Version: 1

CITED1 is a novel binding partner of MITF that influences the MITF-directed transcriptional profile in melanoma

Barbara Lettiero, Martin Lauss, Ake Borg, Sofia Gruvberger-Saal, Goran B Jönsson, Jillian Howlin

https://doi.org/10.7287/peerj.preprints.3146v1

December 11, 2014 - Version: 1

Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours

Jill Howlin, Helena Cirenajwis, Barbara. Lettiero, Johan Staaf, Martin Lauss, Lao Saal, Åke Borg, Sofia K Gruvberger-Saal, Göran B Jönsson

https://doi.org/10.7287/peerj.preprints.686v1

October 9, 2014 - Version: 2

Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours

Jill Howlin, Helena Cirenajwis, Barbara. Lettiero, Johan Staaf, Martin Lauss, Lao Saal, Åke Borg, Sofia K Gruvberger-Saal, Göran B Jönsson

https://doi.org/10.7287/peerj.preprints.516v2